بهترین پادکست های Targeted Talks (2024)

1
S5 Ep9: Unlocking the Potential of Technology in Community Oncology 25:49

7d ago25:49

25:49

In this episode of Targeted Talks, Nini Wu, MD, MBA, chief medical and development officer at Cardinal Health, shares her insights on the ever-changing world of technology in the community oncology setting.توسط Targeted Talks

1
S5 Ep8: LaPelusa’s Journey in the Dynamic Field of GI Oncology 14:20

21d ago14:20

14:20

In the latest episode of Emerging Experts, Michael LaPelusa, MD, hematology and oncology fellow at MD Anderson Cancer Center, shares his insights, experiences, and passion for cancer research, particularly in the realm of gastrointestinal cancers.توسط Targeted Talks

1
S5 Ep7: The Future of Breast Cancer Care: Blackwood on Personalized Approaches 26:53

1M ago26:53

26:53

In this episode of Targeted Talks, M. Michele Blackwood, MD, FACS, director of breast surgery, Robert Wood Johnson (RWJ), Barnabas Health, director of women’s oncologic health, RWJ Barnabas Health and Rutgers Cancer Institute, and head of breast surgery, Cooperman Barnabas Medical Center, discusses the current landscape of breast cancer treatment a…

1
S5 Ep6: Dizman’s Global Pursuit to Cancer Research and Understanding 19:05

2M ago19:05

19:05

In this episode of Emerging Experts, Nazli Dizman, MD, shares the intricacies of her journey towards becoming an oncologist in the United States.توسط Targeted Talks

1
S5 Ep5: FDA Approval Marks Amivantamab's Milestone in EGFR+ NSCLC 22:32

2M ago22:32

22:32

In this episode, Joshua K. Sabari, MD, discusses the FDA approval of amivantamab plus chemotherapy as a first-line treatment for patients with EGFR exon 20 insertion mutation-positive non-small cell lung cancer.توسط Targeted Talks

1
S5 Ep4: Enhancing Precision in Immunotherapy: CD8 PET-Avidity in RCC 19:03

3M ago19:03

19:03

In this episode of Emerging Experts, Peter Zang, MD, highlights research on baseline CD8 lymph node avidity with 89-Zr-crefmirlimab for the treatment of patients with metastatic renal cell carcinoma and response to immunotherapy.توسط Targeted Talks

1
S5 Ep3: Advancing Myeloma Treatment With Blood-Based MRD Testing 22:04

3M ago22:04

22:04

In season 5, episode 3 of Targeted Talks, Ben Derman, MD, assistant professor of medicine at the University of Chicago Medical Center, dissects the latest advancements in myeloma treatment, focusing on the role of ClonoSeq and minimal residual disease monitoring.توسط Targeted Talks

1
S5 Ep2: Beyond the First-Line: Economides on Advancing Therapies in RCC 20:06

4M ago20:06

20:06

In our 4th episode of Emerging Experts, Minas P. Economides, MD, assistant professor of medicine at NYU Langone Perlmutter Cancer Center, unveils the challenges and opportunities for renal cell carcinoma treatment, focusing on the lack of therapies available in the second-line setting.توسط Targeted Talks

1
S5 Ep1: A Deep Dive Into the Evolving Landscape of Prostate Cancer 23:52

4M ago23:52

23:52

In season 5, episode 1 of Targeted Talks, Badrinath Konety, MD, president of the Allina Health Cancer Institute and the chief academic officer for Allina Health, delves into the critical topic of prostate cancer screening, particularly for men within a community setting, and discusses some of the recent advancements in the prostate cancer space.…

1
S4 Ep20: Lisberg Discusses Dato-DXd's Role in Advanced Lung Cancer Care 15:49

5M ago15:49

15:49

In season 4, episode 20 of Targeted Talks, Aaron Lisberg, MD, a thoracic medical oncologist at the University of California, Los Angeles, delves into findings from the phase 3 TROPION-Lung01 study of datopotamab deruxtecan for the treatment of patients with advanced or metastatic non–small cell lung cancer.…

1
Target Talks: Building Trust and Impact with Adrian Jones 28:26

6M ago28:26

28:26

In this episode of Target Talks, Sarah Bryars sits down with Adrian Jones, Group Head of PR at the Benefact Group to discuss the role of PR in delivering their organisation’s purpose. Adrian begins by introducing listeners to the unique set-up of the Benefact Group and how it has evolved since its beginnings 135 years ago, to insure some of today’s…

1
S4 Ep19: Navigating the Landscape of Immunotherapy Toxicities 15:57

6M ago15:57

15:57

In our third episode of Emerging Experts, host Jordyn Sava is joined by Matthew Hadfield, DO, a third-year hematology/oncology fellow at Brown University, to discuss his interest and research in immunotherapy toxicities.توسط Targeted Talks

1
Target Talks: Taking Purposeful Action with Josephine Osborne 17:26

6M ago17:26

17:26

In this episode of Target Talks, Sam Kandiyali is joined by Josephine Osborne, Senior Project Manager at Specsavers. Jo begins by talking about Specsavers’ work in improving lives through better sight and hearing – the organisation’s purpose. She introduces listeners to Specsavers Homelessness programme which focuses on making eye and hearing care …

1
Delivering Purposeful Visual Communications 47:31

6M ago47:31

47:31

In this episode of Target Talks, Sarah Bryars and Sam Kandiyali are joined by Spencer McPherson, Chief Creative Officer of Still Moving, a creative agency who produce dynamic and engaging photography and film for brands around the world. Spencer begins (and ends) this episode by sharing stories of some of the many famous faces he has photographed, …

1
S4 Ep18: Behind the FDA Approval of Fruquintinib for Previously Treated mCRC 9:24

6M ago9:24

9:24

In season 4, episode 18 of Targeted Talks, Arvind Dasari, MD, MS, dives into the recent approval of fruquintinib for patients with with metastatic colorectal cancer.توسط Targeted Talks

1
Target Talks: Creating Positive Change with Simone Hindmarch 34:38

6M ago34:38

34:38

On this episode of Target Talks, Sarah Bryars is joined by Simone Hindmarch, Co-founder and Managing Director of Commercial. Simone begins by telling us how, back in 2006, an invite to a client’s screening of An Inconvenient Truth became an ‘epiphany moment’ for her and kickstarted Commercial’s sustainability journey. Sarah and Simone discuss the i…

1
Target Talks: The Power of Social Media with Luan Wise 28:34

7M ago28:34

28:34

On this episode of Target Talks, Sarah Bryars and Sam Kandiyali sit down with Luan Wise, social media consultant and founder of The Lighthouse. As Luan tells us, she wasn’t one of social media’s first adopters– in fact, she was adamant that it wouldn’t take off... but that was back in 2007. She shares how she made the leap from account manager at a…

1
S4 Ep17: Bridging Science and Compassion in Cancer Care 20:24

7M ago20:24

20:24

In this episode of Emerging Experts, host Jordyn Sava is joined by Hemali Batra-Sharma, MD, fellow, Hematology/Oncology, University of California San Diego (UCSD) Medical Center, UCSD Health, to discuss insights into her passion for oncology and some of the experiences that have helped to shape her career.…

1
Target Talks: The Pillars of Purpose with Frank Nigriello 28:11

7M ago28:11

28:11

On the first episode of Target Talks, Sam Kandiyali is joined by Frank Nigriello, Director of Corporate Affairs at Unipart Group. Frank begins by sharing what purpose means to him in his role at Unipart, and the part that purpose plays in decision-making. Sam and Frank chat about the Pillars of Purpose model, and how PR can help businesses to build…

1
Target Talks: Purposeful PR Trailer 1:32

7M ago1:32

1:32

If you’re thinking about how you and your organisation can be a force for good, this podcast is a must listen. The six-episode series, brought to you by Target, an award-winning UK communications agency, explores different aspects of purposeful PR and communications. From building communities, to storytelling, engaging stakeholders and influencing …

1
S4 Ep16: Tailoring Treatments to Better Outcomes in Liver Cancer 25:35

7M ago25:35

25:35

In season 4, episode 16 of Targeted Talks, Susanne G. Warner, MD, hepatobiliary and pancreas surgeon at the Mayo Clinic in Rochester, Minnesota, discusses the importance of tailoring treatments for patients with liver cancer, taking into account the staging of the cancer.توسط Targeted Talks

1
S4 Ep15: Desai on Embracing Curiosity and Change in the Oncology Field 11:50

8M ago11:50

11:50

In our first episode of Emerging Experts, Aakash Desai, MD, MPH, discusses his journey through the oncology field by reminiscing on the encouraging guidance of his mentors, personal research goals, and his experiences thus far as an oncologist.توسط Targeted Talks

1
S4 Ep14: First Real-World Data on Second-Generation AR Inhibitor Use in nmCRPC 7:52

8M ago7:52

7:52

Alicia Morgan, MD, MPH on real-world data from the DEAR study.توسط Targeted Talks

1
S4 Ep13: Strategies for Neoadjuvant NSCLC Treatment 10:04

9M ago10:04

10:04

An interview with Benny Weskler, MBA, MD, FACS, FACCP of Allegheny Health Network.توسط Targeted Talks

1
S4 Ep12: Lessons from Real-World Cases of Small Cell Lung Cancer 16:53

9M ago16:53

16:53

Federico Albrecht, MD discusses 2 small cell lung cancer cases.توسط Targeted Talks

1
S4 Ep11: Social Determinants of Health Impacting Oncology Today 10:16

10M ago10:16

10:16

توسط Targeted Talks

1
S4 Ep10: Recommendations for Treating Central Nervous Systems Cancers 8:19

10M ago8:19

8:19

Craig Horbinski, MD, PhD, unpacks the NCCN Clinical Practice Guidelines for central nervous system tumors.توسط Targeted Talks

1
S4 Ep9: Mitigating Cardiotoxicity Resulting from Immune Checkpoint Inhibitor Therapy 12:43

11M ago12:43

12:43

In season 4, episode 9 of Targeted Talks, Kerry Reynolds, MD of Massachusetts General Hospital discusses the occurrence of myocarditis in patients with cancer treated with immune checkpoint inhibitors.توسط Targeted Talks

1
S4 Ep8: Pushing Forward With Molecularly-Driven Precision Medicine in Endometrial Cancer 21:12

11M ago21:12

21:12

An interview with Ruchi Garg, MD of City of Hope.توسط Targeted Talks

1
S4 Ep7: Exciting Activity in Chronic Lymphocytic Leukemia 8:05

12M ago8:05

8:05

توسط Targeted Talks

1
S4 Ep6: Anticipating Novel Treatments for the RAI-Refractory DTC Armamentarium 8:32

1y ago8:32

8:32

An interview with Warren Swegal, MD.توسط Targeted Talks

1
S4 Ep5: Advancing the Treatment of Alveolar Soft Part Sarcoma 13:16

1y ago13:16

13:16

An interview with Alice P. Chen, MD of the National Cancer Institute.توسط Targeted Talks

1
S4 Ep4: Understanding and Treating Mucosal Melanoma 11:44

1y ago11:44

11:44

Richard D. Carvajal, MD, discusses mucosal melanoma and treatment options for the disease.توسط Targeted Talks

1
S4 Ep3: Hitting New Targets in Metastatic Prostate Cancer 12:31

1y ago12:31

12:31

In season 4, episode 3 of Targeted Talks, Pedro Barata, MD, MSc, discusses the present and future of prostate cancer precision medicine.توسط Targeted Talks

1
S4 Ep2: The Importance of Trastuzumab Deruxtecan in HER2+ Breast Cancer Treatment 9:48

1y ago9:48

9:48

A talk with Sara A. Hurvitz, MD about advances in the HER2-positive breast cancer space.توسط Targeted Talks

1
S4 Ep1: Unpacking the Latest Research in Gastrointestinal Cancers 17:36

1+ y ago17:36

17:36

In season 4, episode 1 of Targeted Talks, Benjamin L. Schlechter, MD, of Dana-Farber Cancer Institute discuses new studies in gastrointestinal malignancies.توسط Targeted Talks

1
S3 Ep10: A More Precise Approach to Small Cell Lung Cancer Treatment 21:04

1+ y ago21:04

21:04

In season 3, episode 10 of Targeted Talks, Nitika Sharma, MD of Cancer Treatment Centers of America Atlanta, discusses FDA-approved and promising novel therapies for the treatment of small cell lung cancer.توسط Targeted Talks

1
S3 Ep9: Special Episode: Managing Cardiotoxicity from ICI Therapy in Patients with Cancer 17:45

1+ y ago17:45

17:45

In season 3, episode 9 of Targeted Talks, Mohammed Salhab, MD, Chris Fine, MD, FACC, cardiologist at National Jewish Health, have a special discussion about cardiotoxicity from immune checkpoint inhibitor therapy in patients with cancer.توسط Targeted Talks

1
S3 Ep8: Treating HER2-Positive Beast Cancer in the Community Setting 17:24

1+ y ago17:24

17:24

In season 3, episode 8 of Targeted Talks, Christie J. Hilton, DO, discusses treating first- and second-line HER2-positive breast cancer.توسط Targeted Talks

1
S3 Ep7: The Evolution of Endometrial Cancer Treatment 9:36

2y ago9:36

9:36

In season 3, episode 7 of Targeted Talks, John Nakayama, MD, a gynecologic oncologist at Allegheny Health Network, discusses updates in the endometrial cancer treatment landscape.توسط Targeted Talks

1
S3 Ep6: Examining the Non-Hodgkin Lymphoma Treatment Paradigm 12:36

2y ago12:36

12:36

Yazan Samhouri, MD, discusses the exciting new agents for the treatment of non-Hodgkin lymphoma, the clinical trials that support their use, and hopes for the future of treatment.توسط Targeted Talks

1
S3 Ep5: The Road to Improving Diffuse Large B-Cell Lymphoma Treatment 8:47

2y ago8:47

8:47

In season 3, episode 5 of Targeted Talks, Thomas Habermann, MD, discusses the latest advances in the treatment of diffuse large B-cell lymphoma.توسط Targeted Talks

1
S3 Ep4: Better Strategies for the Treatment of High-Risk Chronic Lymphocytic Leukemia 10:37

2y ago10:37

10:37

In season 3, episode 4 of Targeted Talks, Alexey Danilov, MD, PhD, discusses the shift toward utilizing cellular therapy to treat high-risk patients with chronic lymphocytic leukemia.توسط Targeted Talks

1
S3 Ep3: Unpacking the New Recommendations for Early-Stage Breast Cancer Management 13:16

2y ago13:16

13:16

In season 3, episode 3 of Targeted Talks, William J. Gradishar, MD, discusses the latest version of the NCCN Clinical Practice Guidelines for managing early-stage breast cancer.توسط Targeted Talks

1
S3 Ep2: Advances and Pending Innovations in the Treatment of Sarcoma 18:39

2y ago18:39

18:39

Mark Agulnik, MD, City of Hope Comprehensive Cancer Center joins Targeted Oncology for a discussion about the sarcoma treatment landscape and pending innovations under investigation in clinical trials.توسط Targeted Talks

1
S3 Ep1: A Look Inside the Toolbox for BRAF-Mutant Metastatic Melanoma 9:24

2+ y ago9:24

9:24

In season 3, episode 1 of Targeted Talks, Michael A. Postow, MD, discusses available targeted agents for BRAF-mutant melanoma and ongoing clinical questions about treating the disease.توسط Targeted Talks

1
S2 Ep10: Treating Sarcoma With a Multidisciplinary Approach 16:37

2+ y ago16:37

16:37

Sandra P. D'Angelo, MD and Katherine Poruk, MDتوسط Targeted Talks

1
S2 Ep9: Sequencing Therapy for Metastatic Castration-Resistant Prostate Cancer 17:57

2+ y ago17:57

17:57

In season 2, episode 9 of Targeted Talks, Sandy Srinivas, MD and Nicholas J. Vogelzang, MD, discuss he optimal sequencing of therapies for a specific patient with metastatic castration-resistant prostate cancer.توسط Targeted Talks

1
S2 Ep8: New Targeted Therapies in Renal Cell Carcinoma 41:27

2+ y ago41:27

41:27

In season 2, episode 8 of “Targeted Talks,” Thomas Hutson, DO, PharmD, and Rana R. McKay, MD, of UC San Diego Health, discussed the renal cell carcinoma paradigm and challenges to overcome in the future.توسط Targeted Talks

پادکست هایی که ارزش شنیدن دارند

پادکست های Targeted Talks

پادکست هایی که ارزش شنیدن دارند

راهنمای مرجع سریع